Association of DNA Promoter Methylation and
BRAF mutation
RAS signaling
TNFR2
methylation
thyroid carcinoma
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
02 03 2023
02 03 2023
Historique:
received:
07
02
2023
accepted:
28
02
2023
medline:
30
3
2023
entrez:
28
3
2023
pubmed:
29
3
2023
Statut:
epublish
Résumé
The
Identifiants
pubmed: 36975440
pii: curroncol30030227
doi: 10.3390/curroncol30030227
pmc: PMC10047424
doi:
Substances chimiques
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
DNA
9007-49-2
BRAF protein, human
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2978-2996Subventions
Organisme : NCI NIH HHS
ID : P20 CA210305
Pays : United States
Références
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
J Clin Med. 2022 Aug 21;11(16):
pubmed: 36013156
Thyroid. 2006 Jul;16(7):633-42
pubmed: 16889486
Front Endocrinol (Lausanne). 2020 Mar 13;11:102
pubmed: 32231639
Sci Signal. 2017 Jan 17;10(462):
pubmed: 28096513
PLoS One. 2011 Jan 17;6(1):e14522
pubmed: 21264207
J Endocrinol Invest. 2018 Feb;41(2):163-170
pubmed: 28612287
Endocrinol Metab (Seoul). 2022 Dec;37(6):879-890
pubmed: 36604958
Crit Rev Oncol Hematol. 2021 Jun;162:103353
pubmed: 34000414
Endocr Connect. 2018 Dec 1;7(12):1226-1235
pubmed: 30352402
Exp Mol Med. 2014 Nov 07;46:e120
pubmed: 25378232
Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101656
pubmed: 35461756
Nat Rev Dis Primers. 2015 Dec 10;1:15077
pubmed: 27188261
Clin Epigenetics. 2017 May 2;9:45
pubmed: 28469731
J Cell Biochem. 2013 May;114(5):1174-82
pubmed: 23192464
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099
pubmed: 28938489
Eur J Endocrinol. 2023 Jan 10;188(1):
pubmed: 36651156
Epigenetics. 2012 Jul;7(7):710-9
pubmed: 22694820
Trends Genet. 2000 Apr;16(4):168-74
pubmed: 10729832
JAMA Surg. 2014 Nov;149(11):1146-52
pubmed: 25229773
Gland Surg. 2022 Dec;11(12):1908-1923
pubmed: 36654945
Cytopathology. 2016 Apr;27(2):122-30
pubmed: 25988212
Case Rep Oncol. 2022 Nov 8;15(3):960-966
pubmed: 36636677
J Clin Endocrinol Metab. 2013 Jul;98(7):2811-21
pubmed: 23666970
J Otolaryngol Head Neck Surg. 2021 Nov 6;50(1):63
pubmed: 34742355
Endocrine. 2013 Feb;43(1):225-9
pubmed: 22945693
Front Oncol. 2023 Jan 12;12:1057532
pubmed: 36713542
Endocr Relat Cancer. 2019 Feb 1;26(4):451-462
pubmed: 30753136
Endocr Relat Cancer. 2011 Nov 14;18(6):687-97
pubmed: 21937738
Iran J Public Health. 2022 Mar;51(3):634-642
pubmed: 35865047
Clin Cancer Res. 2019 Jan 15;25(2):544-551
pubmed: 30093451
Sci Rep. 2017 Mar 08;7:44033
pubmed: 28272462
Int J Mol Sci. 2017 Jun 17;18(6):
pubmed: 28629126
J Transl Med. 2023 Jan 9;21(1):9
pubmed: 36624452
Head Neck. 2022 Jun;44(6):1277-1300
pubmed: 35274388
Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):709-713
pubmed: 29271794
J Clin Endocrinol Metab. 2014 Feb;99(2):E329-37
pubmed: 24423287
Endocr Relat Cancer. 2019 Jul;26(7):R415-R439
pubmed: 31035251
J Cell Physiol. 2020 Oct;235(10):6954-6968
pubmed: 32017063
Surgery. 2013 Dec;154(6):1255-61; discussion 1261-2
pubmed: 24383114
Front Oncol. 2022 Apr 14;12:862154
pubmed: 35494080
Front Endocrinol (Lausanne). 2022 Oct 24;13:1008301
pubmed: 36353231
Ann Surg Oncol. 2016 Jul;23(7):2302-9
pubmed: 26979305
Lab Invest. 2005 Sep;85(9):1065-75
pubmed: 15980887
Mol Cancer. 2007 Apr 02;6:24
pubmed: 17407548
Int J Cancer. 2014 Aug 1;135(3):598-610
pubmed: 24382797
BMC Res Notes. 2012 Feb 22;5:117
pubmed: 22357164
Cancer Cell Int. 2021 Dec 19;21(1):687
pubmed: 34923978
Trends Mol Med. 2017 Nov;23(11):1037-1046
pubmed: 29032004
Science. 2018 Oct 12;362(6411):
pubmed: 30309915
Biometrics. 1947 Mar;3(1):1-21
pubmed: 20240414
Front Endocrinol (Lausanne). 2022 Mar 14;12:736068
pubmed: 35370931
Oncogene. 2018 Jun;37(24):3183-3199
pubmed: 29540830
Endocr Pathol. 2023 Mar;34(1):112-118
pubmed: 36709221
Anticancer Res. 2015 Apr;35(4):2279-85
pubmed: 25862890
Clin Exp Otorhinolaryngol. 2022 Aug;15(3):273-282
pubmed: 35538718
J Clin Endocrinol Metab. 2014 Jun;99(6):E944-52
pubmed: 24432988
Ann Surg. 2007 Sep;246(3):466-70; discussion 470-1
pubmed: 17717450
J Clin Endocrinol Metab. 2005 Jul;90(7):4011-8
pubmed: 15840741
Cancer Res. 2002 Jul 1;62(13):3698-701
pubmed: 12097277
Medicine (Baltimore). 2012 Sep;91(5):274-286
pubmed: 22932786
Cancer Cell Int. 2022 Oct 11;22(1):310
pubmed: 36221112
Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101680
pubmed: 35691860
Endocr Relat Cancer. 2008 Sep;15(3):801-15
pubmed: 18753363
Diagn Cytopathol. 2023 Jan;51(1):36-50
pubmed: 36480743
Oncotarget. 2015 Nov 17;6(36):39211-24
pubmed: 26472282
Cells. 2022 Jun 17;11(12):
pubmed: 35741080
Cancers (Basel). 2022 Dec 30;15(1):
pubmed: 36612238
Genome Med. 2014 Aug 26;6(8):61
pubmed: 25191524
Sci Signal. 2021 Apr 13;14(678):
pubmed: 33850055
JAMA. 2017 May 09;317(18):1882-1887
pubmed: 28492905
Acta Cytol. 2003 Sep-Oct;47(5):709-22
pubmed: 14526667
Eur J Endocrinol. 2022 Jul 19;187(3):335-347
pubmed: 35895726
Endocrine. 2022 Feb;75(2):487-494
pubmed: 34689317
Cancers (Basel). 2018 Nov 13;10(11):
pubmed: 30428594
J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440
pubmed: 30545990